Improving Taste to Enhance Medication Adherence
Formulation and excipient advances address taste masking concerns to improve medication adherence in pediatric, geriatric, and other special patient populations.
Taking a Holistic Approach for Data Governance
As regulatory authorities crack down on data integrity violations, bio/pharma companies must ensure adequate data governance programs are in place.
Does Your Endotoxin Detection Method Ensure Patient Safety?
Understanding the relative strengths and weaknesses of different endotoxin test methods is crucial to maintaining quality and patient safety.
Lonza in Gene Therapy Licensing Agreements
Lonza has entered into strategic license agreements for exclusive rights to a gene-therapy platform for developing treatments for hearing and balance disorders.
Will Pharma Meet the Drug Tracking Deadline?
Manufacturers and trading partners struggle to meet drug tracking requirements
Recipharm Equips Three More Facilities for US Serialization
The facilities in Brescia, Italy and Karlskoga and Uppsala, Sweden, are the latest of Recipharm’s sites to be equipped to supply serialized products to the United States.
Best Weighing Practices in the Pharmaceutical Industry
Understanding what affects a measurement and implementing appropriate procedures will aid weighing accuracy.
Avista Doubles API Manufacturing Capacity at Colorado Facility
Avista Pharma Solutions facility and equipment upgrades at its Longmont, Colorado facility support processing of potent compounds.
Integrated Analytical Software Solutions for Clinical and Regulatory Processes
MasterControl has added three new cloud-based analytical solutions to its MasterControl Version 11.7 software for clinical managers and regulatory/submissions professionals.
Cambrex Expands Small-Scale Capacity at Iowa Facility
The company has completed a small-scale capacity expansion at its site in Charles City, IA.
Nitto Avecia Completes Large-Scale Synthesis of Oligonucleotide
Company completes first successful run of what is believed to be the largest synthesis-scale done for oligonucleotide APIs.
Alcami in API Manufacturing Pact with Solasia
Alcami will manufacture clinical supply of the API for a drug candidate targeting various hematologics and solid cancers.
QuintilesIMS Changes Name to IQVIA
QuintilesIMS has changed its name to IQVIA to reflect its October 2016 merger with IMS Health.
Vetter Expands in Asia-Pacific
The company has officially opened a local brand office in South Korean to support its existing business in the region.
Biosimilars Raise Analytical and Policy Challenges
The debate continues over biosimilar naming, interchangeability, and patent protection, as well as lingering concerns in the medical community about the safety of switching patients to new therapies.
CDMOs Add Capabilities to Build Strategic Biopharma Capabilities
Acquisition activity has created some CDMOs with facilities and capabilities that rivals global bio/pharma companies.
